The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re Director Share Purchases and Correction

10 Nov 2014 07:00

RNS Number : 5552W
Quindell PLC
10 November 2014
 



 

Quindell Plc ("Quindell", the "Company" or the "Group")

Further re Director Share Purchases and Correction

 

On 5th November 2014, the Company announced that three directors of the Company, Robert Terry, Laurence Moorse, and Steve Scott ("the Purchasing Directors") had entered into agreements with Equities First Holdings LLC ("EFH") (the "Agreements" or "Agreement" as the case may be) (the "Announcement"). The Announcement stated that the Purchasing Directors had entered into the Agreements to facilitate the initial purchase, in aggregate, of 1,575,000 ordinary shares of 15 pence each in the Company ("Ordinary Shares"). It was announced on 7th November 2014, that a further purchase of 175,000 Ordinary Shares had been made by Bickleigh Ridge Limited, a company controlled by Steve Scott and his immediate family, such purchase also having been financed pursuant to an Agreement with EFH (the "Further Announcement").

 

Clarification

Whilst the Board of Quindell (the "Board") understands that the Announcement followed a format consistent with announcements made by other AIM companies where directors had entered into similar arrangements with EFH, the Board wishes to provide further disclosure and clarification in relation to the Agreements as referred to in the Announcement and Further Announcement. Terms defined in the Announcement have the same meanings in this one.

 

Under the Agreement, which is a sale and repurchase agreement intended to provide financing to the Purchasing Directors, the Purchasing Directors transferred the legal and beneficial interest in a number of shares to EFH (the "transferred shares") in return for the Purchasing Directors receiving a payment from EFH of a sum equal to 67 per cent of the three-day average market value per share less a financing arrangement fee of 3 per cent. (the "EFH Purchase Price"). Further details of the transfers made are set out in the table below. As the legal and beneficial holder of the transferred shares, EFH may take any action it deems appropriate in relation to the transferred shares and is under no obligation to hold or retain the transferred shares though it has undertaken not to vote them. In addition, EFH has represented and warranted to the Purchasing Directors that it will not borrow Ordinary Shares for short selling activities and that its broker/ dealer or depository institutions will not engage in any short selling activity with any shares transferred under the Agreement and held on account by them.

 

On the maturity date of the Agreement (two years from the payment of the EFH Purchase Price), the Purchasing Directors are contractually obliged and have informed the Company that they fully intend to, purchase the transferred shares or equivalent shares from EFH at a price equal to 69 per cent. of the three-day average market value per share applicable at the date of entering into the facility, less margin calls paid, and EFH is required to deliver the transferred shares or equivalent shares to each Purchasing Director on payment.

 

If, prior to the maturity date, the value of the transferred shares falls to 80 per cent. or less of the value at which they were transferred to EFH, being 67 per cent. of the three-day average market value at the time when the relevant transfer was made, the Purchasing Directors will be required to transfer further Ordinary Shares or provide cash to satisfy margin calls. In the event that any further Ordinary Shares are transferred to EFH pursuant to the Agreements, or any similar agreements are entered into, a further announcement will be made.

 

  

Correction of Rights

The table below is a restatement of certain information contained in the Announcement and has been expanded to incorporate a correction that reflects the timing of the transfer of Ordinary Shares to EFH, which the Purchasing Directors have been advised should be regarded as having occurred on 5 November 2014, when the facility monies were advanced. The Purchasing Directors remain interested in the transferred shares by reason of the repurchase obligation contained in the Agreements. Further announcements will be made on each occasion that Ordinary Shares are transferred under the Agreements.

 

 

Name/position

No. of Ordinary Shares prior to transfer of shares under facility

No. of Ordinary Shares transferred to EFH pursuant to the facility(and to be repurchased)

to date

Aggregate EFH Purchase Price, less 3 per cent facility fee

(£)

 No. of Ordinary Shares purchased and average price paid

No. of Ordinary Shares with voting rights held after transactions and as a % of the Company

Total interest in Ordinary Shares and as a % of the Company (2)

 

Robert Terry,

 Chairman

45,650,000(1)

8,850,000(2)

7,465,596

1,000,000 at 123.47p

37,800,000(1) (8.66%)

46,650,000 (1) (10.69%)

Laurence Moorse, Group Finance Director

1,196,666

200,000(2)

168,714

50,000

at 123.00p

1,046,666 (0.24%)

1,246,666 (0.29)%

Steve Scott,

525,000(1)

at 123.83p

and

175,000(1)

at 120.88p

Non-Executive Director

5,112,992(1)

1,350,000(2)

1,138,820

4,462,992(1) (1.02%)

5,812,992(1) (1.33%)

The total issued ordinary share capital of the Company comprises 436,345,424 Ordinary Shares.

(1) Includes Ordinary Shares held as family interests or by virtue of position as beneficiary or potential beneficiaries of certain trusts or companies.

(2) As stated above, under the Agreements the Directors have agreed to repurchase the transferred shares or equivalent shares at a price calculated by reference to the value at the time of the Agreements at the end of the two year period. For this reason the Directors continue to have an interest in these Ordinary Shares and they are therefore included in their total interest in Ordinary Shares.

 

 

Robert Terry, Chairman of Quindell said: "As previously stated and as demonstrated by the initial purchases made by the Purchasing Directors and the fact that the majority of the board has acquired shares recently, we believe the current market valuation of the Company is materially below its true value.

 

In entering into the sale and repurchase agreements to provide finance, each of us Purchasing Directors relied upon assurances from EFH that, notwithstanding EFH's legal rights, the custom and practice of EFH was that the shares transferred would not be disposed of outright, other than in a default event and will be held by their custodians throughout the term of the agreement, nor would they engage in short selling activity.

 

We have made this further announcement to ensure the market is aware of the actual number of shares transferred to date under the Agreements. Further announcements will be made when more shares are to be used to fund further purchases of Quindell shares in the future. For clarity, purchasing shares at the current valuation has been the motivation for entering into the Agreements. The Agreements are purely to provide funding for a two year term and I and Laurence intend to use the funds received under the Agreement to purchase Quindell shares and to cover any associated potential tax liabilities and margin calls relating to the Agreements, with Steve Scott intending to do the same and also cover certain other tax liabilities.

 

The Agreements would not have been entered into if the board did not remain confident of meeting full year market expectations and of the Company's longer term prospects."

 

For further information:

 

Quindell PlcRobert Terry, Chairman

 

Laurence Moorse, Group Finance Director

 

Stephen Joseph, Head of Investor Relations

 

Tel: 01489 864201

terryr@quindell.com

Tel: 01489 864205

moorsel@quindell.com

Tel: 01489 864200

josephs@quindell.com

 

 

Cenkos Securities plcJoint Broker and Nominated AdviserStephen Keys/Mark Connelly

 

Canaccord Genuity Limited

Joint Broker and Financial Adviser

Simon Bridges/Bruce Garrow

 

 

Tel: 020 7397 8900

 

 

Tel: 020 7523 8000

 

 

 

Media EnquiriesRedleaf Polhill Limited

Rebecca Sanders-Hewett/Jenny Bahr

 

Bell Pottinger

Victoria Geoghegan/Will Powell

 

Tel: 020 7382 4730

quindell@redleafpr.com

 

 

Tel: 020 3772 2562

Quindell@bellpottinger.com

 

 

For further information, please visit www.quindell.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQKKDQNBDKKDD
Date   Source Headline
7th Jul 20217:00 amRNSCancellation - Watchstone Group PLC
6th Jul 20216:00 pmRNSWatchstone Group
5th Jul 20213:58 pmRNSForm 8.3 - Watchstone Group Plc
5th Jul 20212:05 pmRNSHolding(s) in Company
2nd Jul 20215:56 pmRNSHolding(s) in Company
2nd Jul 20215:09 pmRNSReplacement Form 8 (DD) - Watchstone Group plc
2nd Jul 20214:27 pmRNSHolding(s) in Company
2nd Jul 20212:03 pmRNSForm 8.3 - Watchstone Group Plc
2nd Jul 20211:45 pmGNWMan Group PLC : Form 8.3 - Watchstone Group plc
2nd Jul 202112:39 pmRNSForm 8 (DD) - Watchstone Group plc
2nd Jul 20217:05 amRNSForm 8 (OPD) Watchstone Group plc
1st Jul 20215:08 pmRNSRule 2.9 Announcement
1st Jul 20213:42 pmRNSOffer Update
1st Jul 20212:29 pmRNSForm 8 (DD) - Watchstone Group plc
1st Jul 20212:18 pmRNSOffer for Watchstone Group plc
29th Jun 202111:13 amRNSResult of AGM
24th May 20217:00 amRNSPublication of Accounts, Circular & Notice of AGM
7th May 202111:14 amRNSHolding(s) in Company
6th May 20217:00 amRNSFinal Results
6th May 20217:00 amRNSProposed Cancellation of Admission to AIM
4th May 20217:30 amRNSSuspension - Watchstone Group PLC
23rd Apr 20217:00 amRNSIntention to apply for admission to the AQSE
4th Feb 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20208:36 amRNSHolding(s) in Company
23rd Dec 202011:30 amRNSHolding(s) in Company
18th Dec 20208:22 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSDisposal
28th Oct 20209:38 amRNSResult of Meeting
12th Oct 20203:53 pmRNSHolding(s) in Company
8th Oct 20207:00 amRNSHolding(s) in Company
8th Oct 20207:00 amRNSProposed disposal of the Ingenie Business
29th Sep 20207:00 amRNSHalf-year Report
27th Aug 20207:00 amRNSHolding(s) in Company
7th Aug 202011:22 amRNSClaim against PricewaterhouseCoopers LLP
21st Jul 202010:46 amRNSSecond Share Premium Reduction & Return of Cash
24th Jun 20201:30 pmRNSResult of AGM
11th Jun 20205:52 pmRNSHolding(s) in Company
9th Jun 202011:00 amRNSFirst Share Premium Reduction & Return of Cash
29th May 20207:00 amRNSFurther Return of Cash, Accounts & Notice of AGM
28th May 20203:36 pmRNSHolding(s) in Company
15th May 202010:25 amRNSDirector/PDMR Shareholding
14th May 20201:06 pmRNSDirector/PDMR Shareholding
13th May 20207:00 amRNSFinal Results
28th Apr 20207:00 amRNSRegulatory update – No prosecution of the Company
27th Apr 202010:34 amRNSResult of Meeting
16th Apr 20204:47 pmRNSHolding(s) in Company
16th Apr 20201:39 pmRNSHolding(s) in Company
15th Apr 20209:07 amRNSHolding(s) in Company
9th Apr 20207:00 amRNSProposed Share Premium Reduction & Return of Cash
25th Mar 20209:30 amRNSUpdate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.